CRIS Current Research Information System

MARTELLI, ALBERTO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.521
AS - Asia 11.865
EU - Europa 10.653
SA - Sud America 839
AF - Africa 768
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 4
Totale 40.678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.360
SG - Singapore 3.424
CN - Cina 3.008
VN - Vietnam 2.883
GB - Regno Unito 2.669
IT - Italia 1.721
DE - Germania 1.572
SE - Svezia 1.230
HK - Hong Kong 927
FR - Francia 721
IN - India 607
UA - Ucraina 579
RU - Federazione Russa 575
BR - Brasile 574
IE - Irlanda 381
ZA - Sudafrica 281
EE - Estonia 219
NL - Olanda 210
JP - Giappone 203
FI - Finlandia 195
TG - Togo 165
KR - Corea 127
CH - Svizzera 105
AR - Argentina 102
CI - Costa d'Avorio 97
SC - Seychelles 94
JO - Giordania 89
CA - Canada 88
BD - Bangladesh 80
PH - Filippine 77
ID - Indonesia 73
BG - Bulgaria 71
AT - Austria 69
BE - Belgio 68
HR - Croazia 60
TH - Thailandia 52
EC - Ecuador 51
NG - Nigeria 45
MX - Messico 43
PK - Pakistan 43
TR - Turchia 43
PL - Polonia 37
IQ - Iraq 36
CO - Colombia 31
ES - Italia 31
UZ - Uzbekistan 31
CL - Cile 30
GR - Grecia 29
IR - Iran 24
SA - Arabia Saudita 23
AU - Australia 21
TW - Taiwan 21
EG - Egitto 19
VE - Venezuela 17
RO - Romania 16
CZ - Repubblica Ceca 15
LT - Lituania 15
MY - Malesia 15
MA - Marocco 13
PE - Perù 12
PT - Portogallo 12
ET - Etiopia 11
LB - Libano 11
NP - Nepal 11
PY - Paraguay 11
HU - Ungheria 10
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
JM - Giamaica 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
AL - Albania 6
IL - Israele 6
CR - Costa Rica 5
DK - Danimarca 5
DZ - Algeria 5
HN - Honduras 5
KE - Kenya 5
KZ - Kazakistan 5
NO - Norvegia 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
MD - Moldavia 4
SI - Slovenia 4
SN - Senegal 4
AO - Angola 3
BF - Burkina Faso 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MN - Mongolia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
Totale 40.631
Salva come PNG Salva come JPEG
Città #
Southend 2.311
Singapore 2.270
Fairfield 1.818
Ashburn 1.588
Chandler 1.002
Woodbridge 913
Hong Kong 885
Houston 861
San Jose 860
Santa Clara 848
Wilmington 777
Seattle 768
Cambridge 616
Ann Arbor 614
Princeton 577
Ho Chi Minh City 576
Dong Ket 525
Hanoi 489
Bologna 474
Beijing 381
Dublin 379
Boardman 372
Jacksonville 338
Hefei 291
Lauterbourg 291
Nanjing 275
Westminster 253
Padova 219
Los Angeles 208
Berlin 174
Dallas 174
Lomé 165
Helsinki 164
Tokyo 156
New York 150
Council Bluffs 139
San Diego 133
Saint Petersburg 125
Jinan 124
Buffalo 111
Frankfurt am Main 109
Shenyang 104
Seoul 102
Abidjan 97
Milan 95
Da Nang 89
Amman 88
Changsha 87
Redondo Beach 87
Turin 87
Bremen 81
Bern 78
Redmond 78
Guangzhou 75
Mülheim 73
Nanchang 72
Sofia 70
Haiphong 69
Hebei 67
Brussels 58
Shanghai 58
Tianjin 58
São Paulo 57
Johannesburg 52
Des Moines 48
Florence 48
Chicago 47
Nuremberg 46
Rome 46
London 45
Munich 45
Abeokuta 44
Amsterdam 42
Jiaxing 42
Zhengzhou 42
Dearborn 41
Orem 41
Falkenstein 40
Norwalk 39
Yubileyny 39
Medford 37
Washington 37
Vienna 36
Jakarta 35
Mahé 35
Hải Dương 34
Haikou 33
San Francisco 33
Falls Church 32
Phoenix 32
Redwood City 32
Hangzhou 31
Atlanta 30
Toronto 29
The Dalles 27
Warsaw 27
Wuhan 26
Bühl 25
Can Tho 24
Ningbo 24
Totale 26.599
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 307
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? 304
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 287
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 272
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 258
INPP4B overexpression and c-KIT downregulation in human achalasia. 257
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma 253
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 250
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 240
COMBINING DOT1L INHIBITOR EPZ-5676 WITH SORAFENIB TO TREAT MLL-REARRANGED (MLL-R) PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML) 237
Cancer therapy and treatments during COVID-19 era 235
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene 231
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. 229
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. 223
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 221
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 221
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 220
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases 219
Therapeutic targeting of CK2 in acute and chronic leukemias. 219
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 211
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 208
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 204
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 204
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 204
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. 201
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 200
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 200
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 199
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 198
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 195
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 194
Revisiting nuclear phospholipase C signalling in MDS 194
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 194
Assessment of the effect of sphingosine kinase inhibitors on apoptosis, unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics. 193
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma 193
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia 192
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 192
Nuclear inositides: facts and perspectives. 191
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. 188
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 186
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 184
Inositide signaling in the nucleus: From physiology to pathology. 184
Regulation of nuclear phospholipase C activity 183
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress 183
Cutting edge: the role of mTOR signaling in laminopathies. 183
Frequent Elevation of Akt Kinase Phosphorylation in Blood Marrow and Peripheral Blood Mononuclear Cells from High Risk myelodysplastic Syndrome Patients 182
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 180
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 179
Quantitative immunodetection of key elements of polyphosphoinositide signal transduction in osteoblasts from arthritic patients shows a direct correlation with cell proliferation 179
COMBINAZIONE DI EPZ-5676 E SORAFENIB COME NUOVA STRATEGIA TERAPEUTICA PER IL TRATTAMENTO DELLE LEUCEMIE ACUTE MIELOIDI PEDIATRICHE 178
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. 177
Physiology and pathology of nuclear phospholipase C beta1 176
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 176
Pathobiology and therapeutic relevance of GSK-3 in chronic hematological malignancies. 174
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 174
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 174
GSK-3: a multifaceted player in acute leukemias. 174
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression 173
Nuclear phospholipase C beta1 and cellular differentiation. 173
Monitoring of FLT3 phosphorylation status and its response to drugs by flow cytometry in AML blast cells 173
Advances in Targeting Signal Transduction Pathways. 173
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 173
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 172
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 172
Nuclear protein kinase C 171
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 171
Nuclear inositol lipid metabolism: more than just second messenger generation? 171
Nuclear protein kinase C isoforms and apoptosis 170
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 170
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 170
Signal transduction within the nucleus: Revisiting phosphoinositide inositide-specific phospholipase Cbeta(1). 169
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 169
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion 169
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction 168
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 168
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 168
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 166
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 166
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 163
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 163
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 163
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 163
The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. 162
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 162
Drug discovery targeting the mTOR pathway 162
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 161
The key roles of PTEN in T-cell acute lymphoblastic leukemia development, progression and therapeutic response. 161
A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. 159
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment 158
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells 158
PKR Activity Is Required for Acute Leukemic Cell Maintenance and Growth: A Role for PKR-Mediated Phosphatase Activity to Regulate GSK-3 Phosphorylation. 158
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 158
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 157
The emerging multiple roles of nuclear Akt. 157
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins. 157
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies 156
Significance of subnuclear licalization of key players of inositol lipid cycle. 156
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 156
Nuclear phosphoinositides and their roles in cell biology and disease. 155
Metabolism and signaling activities of nuclear lipids 155
Totale 18.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.135 0 0 0 0 0 0 0 0 0 0 165 970
2021/20225.039 553 135 348 378 446 292 156 352 152 605 808 814
2022/20234.733 547 615 258 680 335 345 211 258 783 88 402 211
2023/20241.371 83 212 123 103 149 290 74 65 43 100 52 77
2024/20255.325 120 849 507 334 1.216 328 372 184 76 229 150 960
2025/202611.581 819 1.217 1.195 848 1.475 814 1.299 596 2.125 901 292 0
Totale 41.460